Recent developments in Kawasaki disease

Current Opinion in Infectious Diseases

Volumn 14, Issue 3, 2001, Pages 357-361

  Freeman, Alexandra F ^a,b   Shulman, Stanford T ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Department of Pediatric Infectious Diseases ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; IMMUNOGLOBULIN G; VASCULOTROPIN;

CORONARY ARTERY ANEURYSM; DOSE RESPONSE; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOGENESIS; PROGNOSIS; REVIEW; SURVIVAL;

EID: 0035001269     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200106000-00017     Document Type: Review

References (31)

1. Kawasaki disease in older children and adolescents
2. Kawasaki syndrome in Jamaica
3. Superantigens, conventional antigens and the etiology of Kawasaki syndrome
4. The etiology of Kawasaki disease: Superantigen or conventional antigen?
5. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome
6. A case of guttate psoriasis following Kawasaki disease
7. Clonal expansion of CD8+ T cells in Kawasaki disease
8. Oligoclonal IgA response in the vascular wall in acute Kawasaki disease
9. IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease
10. Is there an association between Kawasaki disease and Chlamydia pneumoniae?
11. Lack of association between Kawasaki syndrome and Chlamydia pneumoniae infection: An investigation of a Kawasaki syndrome cluster in San Diego County
12. Lack of association between Kawasaki syndrome and infection with parvovirus B19, human herpesvirus 8, TT virus, GB virus C/hepatitis G virus or Chlamydia pneumoniae
13. Kawasaki disease associated with measles virus infection in a monozygotic twin
14. Kawasaki disease associated with varicella: A rare association
15. CD14+CD16+ monocyte subpopulation in Kawasaki disease
16. Increased serum levels of vascular endothelial growth factor in Kawasaki disease
17. Vascular endothelial growth factor in acute Kawasaki disease
18. Remodeling of coronary artery lesions due to Kawasaki disease
19. Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease
20. Abnormal myocardial mechanics in Kawasaki disease: Rapid response to gamma-globulin
21. Overview of pharmacological treatment of Kawasaki disease
22. New perspectives in the drug treatment of Kawasaki disease
23. Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease
24. Prediction of non-responsiveness to intravenous high-dose gamma globulin therapy in patients with Kawasaki disease at onset
25. Corticosteroids in the treatment of the acute phase of Kawasaki disease
26. Initial intravenous gammaglobulin treatment failure in Kawasaki disease
27. Catheter interventional treatment in Kawasaki disease: A report from the Japanese Pediatric Interventional Cardiology Investigation Group
28. Factors related to cardiac sequelae of Kawasaki disease
29. Predictors of coronary artery lesions after intravenous gamma globulin treatment in Kawasaki disease
30. Can heart rate variability predict sudden death? A case of sudden death in a child with severe coronary sequelae of Kawasaki disease